CompositeDriver

CompositeDriver is a computational framework for comprehensively identifying molecular cancer drivers, which is crucial for advancing precision oncology. This tool distinguishes itself by conducting a PanCancer and PanSoftware analysis, leveraging a vast dataset of 9,423 tumor exomes across all 33 The Cancer Genome Atlas (TCGA) projects. Utilizing 26 computational tools, CompositeDriver systematically combines and optimizes the identification of driver genes and mutations, showcasing an innovative approach to analyzing large-scale genomic data.

CompositeDriver has identified 299 driver genes through this extensive analysis, providing valuable insights into their implications across different anatomical sites and cancer or cell types. Moreover, the framework employs sequence- and structure-based analyses to pinpoint over 3,400 putative missense driver mutations, each supported by multiple lines of evidence. The robustness of CompositeDriver's predictions is further underscored by experimental validations, which confirmed 60%-85% of these predicted mutations as likely drivers, demonstrating the tool's high level of accuracy.

An interesting finding from CompositeDriver's analysis is the association of more than 300 microsatellite instability (MSI) tumors with high levels of PD-1/PD-L1, a key indicator for immunotherapy responsiveness. Additionally, the tool identified that 57% of the analyzed tumors harbor putative clinically actionable events, suggesting a significant potential for impacting patient treatment plans and outcomes.